{
    "organizations": [],
    "uuid": "92fa61bccf67b8da20e3861945f64b8d74640f45",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-permits-marketing-of-ai-bas/brief-u-s-fda-permits-marketing-of-ai-based-device-to-detect-certain-diabetes-related-eye-problems-idUSFWN1RO0S7",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S. FDA Permits Marketing Of AI-Based Device To Detect Certain Diabetes-Related Eye Problems",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA PERMITS MARKETING OF FIRST MEDICAL DEVICE TO USE AI TO DETECT GREATER THAN MILD LEVEL OF THE EYE DISEASE DIABETIC RETINOPATHY IN DIABETIC ADULTS\n* U.S. FDA SAYS PERMITTING MARKETING OF IDX-DR TO IDX LLC\n* U.S. FDA SAYS THE DEVICE, CALLED IDX-DR, IS A SOFTWARE PROGRAM THAT USES AN AI ALGORITHM TO ANALYZE IMAGES OF THE EYE TAKEN WITH A RETINAL CAMERA Source text for Eikon:\n ",
    "published": "2018-04-11T23:09:00.000+03:00",
    "crawled": "2018-04-12T14:22:48.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "permit",
        "marketing",
        "first",
        "medical",
        "device",
        "use",
        "ai",
        "detect",
        "greater",
        "mild",
        "level",
        "eye",
        "disease",
        "diabetic",
        "retinopathy",
        "diabetic",
        "adult",
        "fda",
        "say",
        "permitting",
        "marketing",
        "idx",
        "llc",
        "fda",
        "say",
        "device",
        "called",
        "software",
        "program",
        "us",
        "ai",
        "algorithm",
        "analyze",
        "image",
        "eye",
        "taken",
        "retinal",
        "camera",
        "source",
        "text",
        "eikon"
    ]
}